Eruptive keratoacanthoma and squamous cell carcinoma complicating imiquimod therapy: Response to oral acitretin

Australasian Journal of Dermatology

Volumn 52, Issue 1, 2011, Pages 66-69

  Foxton, Glen ^a   Delaney, Tom ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Acitretin; Eruptive keratoacanthoma; Imiquimod; Keratoacanthoma; Multiple keratoacanthoma; Squamous cell carcinoma

Indexed keywords

BUPRENORPHINE; ETRETIN; IMIQUIMOD;

ACTINIC KERATOSIS; AGED; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CELL PROLIFERATION; CRYOSURGERY; CYTOPLASM; DISEASE DURATION; EOSINOPHIL; ERUPTIVE KERATOACANTHOMA; FACE; FEMALE; FOLLOW UP; FOREARM; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; KERATOACANTHOMA; LEG; LEG PAIN; LIVER FUNCTION; NECK; PALPATION; RETICULAR VEIN; SIDE EFFECT; SKIN BLOOD VESSEL; SKIN NODULE; SQUAMOUS CELL; SQUAMOUS CELL CARCINOMA; TELANGIECTASIA; TREATMENT RESPONSE; TUMOR RECURRENCE;

ACITRETIN; AGED, 80 AND OVER; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; KERATOACANTHOMA; KERATOLYTIC AGENTS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 79952052075     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2010.00676.x     Document Type: Article

References (35)

1. Esser AC, Abril A, Fayne S et al. Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with infliximab. J. Am. Acad. Dermatol. 2004; 50: S75-7.
2. Kong HH, Cowen EW, Azad NS et al. Keratoacanthomas associated with sorafenib therapy. J. Am. Acad. Dermatol. 2007; 56: 171-2.
3. Pattee SF, Silvis NG. Keratoacanthoma developing in sites of previous trauma: a report of two cases and review of the literature. J. Am. Acad. Dermatol. 2003; 48: S35-8.
4. Craddock KJ, Rao J, Lauzon GJ et al. Multiple keratoacanthomas arising post-UVB therapy. J. Cutan. Med. Surg. 2004; 8: 239-43. (Pubitemid 41223723)
5. Shaw JC, Storrs FJ, Everts E. Multiple keratoacanthomas after megavoltage radiation therapy. J. Am. Acad. Dermatol. 1990; 23: 1009-11. (Pubitemid 20364356)
6. D'Addario S, Carrington PR. Multiple keratoacanthomas as an untoward response to imiquimod therapy for actinic keratosis. Acta Derm. Venereol. 2006; 86: 366-7. (Pubitemid 44133392)
7. Pini AM, Koch S, Schärer L et al. Eruptive keratoacanthoma following topical imiquimod for in situ squamous cell carcinoma of the skin in a renal transplant recipient. J. Am. Acad. Dermatol. 2008; 59: S116-17.
8. Ganjian S, Ourian AJ, Shamtoub G et al. Off-label indications for imiquimod. Dermatol. Online J. 2009; 15: 4.
9. Schön MP, Schön M. Imiquimod: mode of action. Br. J. Dermatol. 2007; 157: 8-13. (Pubitemid 350179622)
10. Marty CL, Randle HW, Walsh JS. Eruptive epidermoid cysts resulting from treatment with imiquimod. Dermatol. Surg. 2005; 31: 780-2. (Pubitemid 43110111)
11. Bauza A, Del Pozo LJ, Saus C et al. Pemphigus-like lesions induced by imiquimod. Clin. Exp. Dermatol. 2009; 34: e60-2.
12. Cavicchini S, Vezzoli P, Muratori S et al. Morbilliform exanthem induced by imiquimod in a patient with drug-related immunosuppression. Clin. Exp. Dermatol. 2009; 34: 526-7.
13. Yang FC, Jessup C, Dahiya M et al. Pityriasis rubra pilaris exacerbation with topical use of imiquimod. Int. J. Dermatol. 2008; 47: 1076-8.
14. Trevino J, Prieto VG, Hearne R et al. Atypical lymphocytic reaction with epidermotropism and lymphocytic vasculopathic reaction (lymphocytic vasculitis) after treatment with imiquimod. J. Am. Acad. Dermatol. 2006; 55: S123-5.
15. Sriprakash K, Godbilt A. Vitiligo-like depigmentation induced by imiquimod treatment of superficial basal cell carcinoma. Australas. J. Dermatol. 2009; 50: 211-13.
16. Batinac T, Zamolo G, Coklo M et al. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma. Pathol. Res. Pract. 2006; 202: 599-607. (Pubitemid 44057766)
17. Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 2005; 5: 749-59. (Pubitemid 41400849)
18. Sina B, Adrian RM. Multiple keratoacanthomas possibly induced by psoralens and ultraviolet A phototherapy. J. Am. Acad. Dermatol. 1983; 9: 686-8. (Pubitemid 14230565)
19. Cox S. Rapid development of keratoacanthoma after a body peel. Dermatol. Surg. 2003; 29: 201-3. (Pubitemid 36188434)
20. Mamelak AJ, Goldberg LH, Marquez D et al. Eruptive keratoacanthomas on the legs after fractional photothermolysis: report of two cases. Dermatol. Surg. 2009; 35: 513-18.
21. Gewirtzman A, Meirson DH, Rabinovitz H. Eruptive keratoacanthomas following carbon dioxide laser resurfacing. Dermatol. Surg. 1999; 25: 666-8. (Pubitemid 29383475)
22. Chorny JA, Stephens FP, Cohen JL. Eruptive keratoacanthomas in a new tattoo. Arch. Dermatol. 2007; 143: 1457-8.
23. Waring AJ, Takata M, Rehman I et al. Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma. Br. J. Cancer 1996; 73: 649-53. (Pubitemid 26068872)
24. Letzel S, Drexler H. Occupationally related tumors in tar refinery workers. J. Am. Acad. Dermatol. 1998; 39: 712-20. (Pubitemid 28519023)
25. Miot HA, Miot LD, da Costa AL et al. Association between solitary keratoacanthoma and cigarette smoking: a case-control study. Dermatol. Online J. 2006; 28: 2.
26. Forslund O, DeAngelis PM, Beigi M et al. Identification of human papillomavirus in keratoacanthomas. J. Cutan. Pathol. 2003; 30: 423-9. (Pubitemid 36920922)
27. Vandergiff T, Nakamura K, High WA. Generalized eruptive keratoacanthomas of Grzybowski treated with isotretinoin. J. Drugs Dermatol. 2008; 7: 1069-71.
28. Aydin F, Senturk N, Sabanciler E et al. A case of Ferguson-Smith type multiple keratoacanthomas associated with keratoacanthoma centrifigum marginatum: response to oral acitretin. Clin. Exp. Dermatol. 2007; 32: 683-6. (Pubitemid 47609747)
29. Feldman RJ, Maize JC. Multiple keratoacanthomas in a young woman: report of a case emphasizing medical management and a review of the spectrum of multiple keratoacanthomas. Int. J. Dermatol. 2007; 46: 77-9. (Pubitemid 46029731)
30. Annest NM, VanBeek MJ, Arpey CJ et al. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature. J. Am. Acad. Dermatol. 2007; 56: 989-93. (Pubitemid 46720214)
31. Calista D, Morri M. Topical imiquimod for the treatment of keratocanthomas. Eur. J. Dermatol. 2008; 18: 590-1.
32. Yuge S, Godoy DA, Melo MC et al. Keratoacanthoma centri-figum marginatum: response to topical 5-fluorouracil. J. Am. Acad. Dermatol. 2006; 54: S218-19.
33. Cipollaro VA. The use of podophyllin in the treatment of keratoacanthoma. Int. J. Dermatol. 1983; 22: 436-40. (Pubitemid 13001568)
34. Souza CS, Felicio LB, Arruda D et al. Systemic photodynamic therapy as an option for keratoacanthoma centrifigum marginatum treatment. J. Eur. Acad. Dermatol. Venereol. 2009; 23: 101-2.
35. Weedon D. Keratoacanthoma: a personal perspective. Curr. Diagn. Pathol. 2003; 9: 259-65. (Pubitemid 36759400)